These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7137099)

  • 41. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of metastatic estrogen receptor and progesterone receptor status on survival.
    Lower EE; Glass EL; Bradley DA; Blau R; Heffelfinger S
    Breast Cancer Res Treat; 2005 Mar; 90(1):65-70. PubMed ID: 15770528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hormonal receptors and response to treatment of breast cancer: a retrospective evaluation in 60 patients.
    Loven D; Rakowsky E; Stein JA; Geier A; Lunenfeld B
    Isr J Med Sci; 1981; 17(9-10):960-4. PubMed ID: 7309485
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estradiol and progesterone receptors in a case of fibromatosis of the breast.
    Pierce VE; Rives DA; Sisley JF; Allsbrook WC
    Arch Pathol Lab Med; 1987 Sep; 111(9):870-2. PubMed ID: 3632307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A quality control study to assess the inter-laboratory variability of routine estrogen and progesterone receptor assays.
    Zava DT; Wyler-von Ballmoos A; Goldhirsch A; Roos W; Takahashi A; Eppenberger U; Arrenbrecht S; Martz G; Losa G; Gomez F; Guelpa C
    Eur J Cancer Clin Oncol; 1982 Aug; 18(8):713-21. PubMed ID: 6891322
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Standardization of steroid receptor assays in human breast cancer--II. Samples with low receptor content.
    Koenders A; Thorpe SM
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1467-72. PubMed ID: 6685633
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Quality control of the assay of receptors in human breast tumors].
    Pichon MF; Spyratos F; Milgrom E
    Pathol Biol (Paris); 1983 Nov; 31(9):741-5. PubMed ID: 6361671
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Standardization of steroid receptor assays in human breast cancer--III. Selection of reference material for intra- and inter-laboratory quality control.
    Thorpe SM; Koenders A
    Eur J Cancer Clin Oncol; 1986 Aug; 22(8):939-44. PubMed ID: 3770051
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estrogen and progesterone receptor assays in human breast cancer: sources of variation between laboratories.
    Borjesson BW; McGinley R; Foo TM; Smyth C; Toppila M; Compton P; Sarfaty GA
    Eur J Cancer Clin Oncol; 1987 Jul; 23(7):999-1004. PubMed ID: 3666003
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estrogen and progesterone receptor assays, by the EIA method (Abbott), of low-speed supernates of breast-cancer homogenates.
    Hähnel R; Avenell MH; Hähnel E
    Clin Chem; 1989 Nov; 35(11):2226-7. PubMed ID: 2684449
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies on the endogenous activation and inhibition of hormone receptor reaction.
    Chen YM; Vaughn CB
    Anticancer Res; 1984; 4(4-5):273-7. PubMed ID: 6486732
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of lyophilization on steroid receptor behavior, as defined by sucrose density gradient analysis.
    Janes GR; Koenders AJ; Benraad TJ
    J Steroid Biochem; 1982 Oct; 17(4):387-94. PubMed ID: 7132353
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interlaboratory variability in the determination of estrogen receptor and progesterone receptor content in human breast tumors: quality control in Switzerland.
    Zava DT
    Recent Results Cancer Res; 1984; 91():122-8. PubMed ID: 6539493
    [No Abstract]   [Full Text] [Related]  

  • 54. Standardization of steroid receptor assays in human breast cancer--I. Reproducibility of estradiol and progesterone receptor assays.
    Koenders A; Thorpe SM
    Eur J Cancer Clin Oncol; 1983 Sep; 19(9):1221-9. PubMed ID: 6684569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of Estrogen and Progesterone Receptor Antibody Reagents Using Proficiency Testing Data.
    Troxell ML; Long T; Hornick JL; Ambaye AB; Jensen KC
    Arch Pathol Lab Med; 2017 Oct; 141(10):1402-1412. PubMed ID: 28714765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quality control of estrogen receptor assays in The Netherlands.
    Koenders T; Benraad TJ
    Breast Cancer Res Treat; 1983; 3(3):255-66. PubMed ID: 6367854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quality control program of steroid receptor assays: an international study.
    Vermousek I; Számel I; Goerlich M; Brdar B; Cvrtila D; Graf D; Padovan R; Paszko Z; Safarcík K
    Neoplasma; 1992; 39(1):65-9. PubMed ID: 1382235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hormone receptors in breast cancer. History and perspectives].
    Milgrom E
    Pathol Biol (Paris); 1983 Nov; 31(9):721-2. PubMed ID: 6361669
    [No Abstract]   [Full Text] [Related]  

  • 59. Stability of estrogen- and progesterone-receptor concentrations in human uterus tissue.
    Zachariah NY; Chakmakjian ZH
    Clin Chem; 1983 Jun; 29(6):1070-2. PubMed ID: 6851094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Radiometric determination of E2 and Pg and quality control].
    Piffanelli A
    Pathologica; 1987; 79(1059-1060):27-32. PubMed ID: 3441408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.